Document is current
Any future updates will be listed below
-
Authors
Hosszu-Fellous, Krisztina
Poncet, Antoine
Cabecinhas, Ana Rita Goncalves
Schibler, Manuel
Meyer, Benjamin
Prendki, Virginie
Huttner, Angela
Carballo, Sebastian
Pouillon, Mathias
Slankamenac, Ksenija
Bart, Pierre-Alexandre
Bernasconi, Enos
Manuel, Oriol
Mombelli, Matteo
Mueller, Nicolas J.
Kaiser, Laurent
Vetter, Pauline https://orcid.org/0000-0002-9902-5069
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (22 170)
Hôpitaux Universitaires de Genève
University of Geneva
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 19 October 2025
First Online: 24 November 2025
Declarations
:
: The protocol has been reviewed and approved by the competent ethics committee (Commission d’éthique et de la recherche CCER de Genève), CCER 2024-01535. Written informed consent to participate is obtained from all participants or their close family member in case of incapacity to consent.
: Not applicable.
: BM received research funds from Moderna Inc. and is a consultant for Rocketvax AG. The other authors declare that they have no competing interests (Laurent Kaiser, Antoine Poncet, Virginie Prendki, Muller Nicolas, Pauline Vetter, Krisztina Hosszu-Fellous, Sebastian Carballo, Manuel Oriol, Matteo Mombelli, Manuel Schibler, Ana Rita Goncalves, Angela Huttner, Enos Bernasconi, Mathias Pouillon, Pierre-Alexandre Bart, Ksenija Slankamenac).
